Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Gilead Sciences Inc.

Gilead Sciences Inc. (GILD)





Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes new medicines for different medical sectors.

Issuer Information

Exchange: NASDAQ
Market Cap: 85694490248
CEO: John C. Martin
Employees: 5000
Issuer Type: CS
Auditor: Ernst & Young LLP
Last Audit: UQ
CIK: 882095
Sector: Healthcare
Industry: Biotechnology
Sub-Industry: Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturin (325414)
SIC: 2836
Last earning call url:
Slideshare slide url:

Contact Information

Main phone: +1 650 574-3000
Address: 333 Lakeside Drive
Address 2:
State: CA
City / Town: Foster City
Country: USA
Postal Code: 94404


No public videos available.


No Result Found.


Gilead Sciences Inc. (GILD) posted Q2 2014 earnings of $2.36 a share, easily beating the consensus estimate by 58 cents.Sales came in at $6.53 billion, topping earlier estimate by 12%.…
If investors were as practical with their investment portfolio as they are with managing a garden, they might make a lot more money! There are so many analogies between managing…
The biotech bull market is not over. That's the judgment of Reni Benjamin of H.C. Wainwright & Co., who predicts high quality data from a broad range of small- and…
GlobeImmune  (GBIM)  is a biopharmaceutical company established in 1995 focused on developing products for the treatment of cancer and infectious diseases based on its proprietary Tarmogen® platform. It is headquartered…
“The Captain has suggested you wear your safely belt…time to be cautious.” We have had a tremendous ride with the stock market for an extended period of time. Since the…
When progress is made in drug development, value is created. Investors recognize that progress by purchasing shares in companies when milestones—which act as catalysts—are met. The Maxim Group's Senior Managing…
Conatus Pharmaceuticals (CNAT) continues the trend of huge pharmaceutical and biotechnology movers this week, peaking on June 11 at an intraday high of $9.87 a share. The past week has…
Shares of Achillion Pharmaceuticals (ACHN) are roaring ahead in Tuesday action after the U.S. Food and Drug Administration lifted its clinical hold on the Achillion’s experimental drug sovaprevir for treating…
The Food and Drug Administration (FDA) lifted the clinical hold on Achillion Pharmaceuticals Inc.'s (ACHN) study for experimental hepatitis C drug on June 10, eight months after halting the company's research. The…
Monday saw a major tectonic shift in the market for biotech companies. Or, rather, the tectonic shift happened some time ago; Monday was the day a major earthquake finally rippled…


Social Mentions about your company in the last seven days
The Daytrade
29 Jul 14 21:55:37
RT @genefj: @refluxer August approval would be a major earnings boost for the year: $2-3B $GILD
The Daytrade
29 Jul 14 21:54:52
RT @refluxer: $GILD Gilead has FIVE oncology drugs at various stages of clinical development and #Zydelig just kicked open the door.
Market Updates
29 Jul 14 21:21:53
$GILD: Drug cocktails point the way towards relief for all hepatitis C sufferers http://t.co/51ceEfbFF3 http://t.co/fJpNy9a6xy
Eddie Strohmier
29 Jul 14 21:02:36
@RAmirzadeh @jimcramer Have been playing $GILD for the last year. The March sell off threw me for a loop. But I stuck to it and bought more
Daniel HS
29 Jul 14 20:25:05
RT @refluxer: $GILD Gilead has FIVE oncology drugs at various stages of clinical development and #Zydelig just kicked open the door.
Helen Ong
29 Jul 14 19:57:32
MT@Myeloma_Doc Study shows signficant cost of Revlimid use as maintenance therapy in myeloma ($141,311) $CELG $GILD http://t.co/rV7Hz9eja3
29 Jul 14 19:16:02
Fundamental and Technical Analysis of #GileadSciences $GILD http://t.co/9z8keoJOsV
29 Jul 14 18:03:40
$GILD Gilead has FIVE oncology drugs at various stages of clinical development and #Zydelig just kicked open the door.
12Stocks.com Biotech
29 Jul 14 18:02:41
#Biotech #stocks $GILD Gilead Sciences Daily:1.67% Weekly:4.58% YTD:23.82% Trend:100 / 100 http://t.co/Gbee52CfjU
Jorge E. Oliveira
29 Jul 14 17:32:46
Why Gilead Is A Better Buy Than This Rival $GILD $CELG http://t.co/zfnBC9Tfqi
Eric Coddington
29 Jul 14 16:41:51
The Senate Finance Committee is investigating Gilead's pricing of the hepatitis C drug Sovaldi $GILD http://t.co/tyqDTLaTtL via @WSJ
29 Jul 14 16:38:30
$GILD, $PLT, $BDSI, $VNR stocks I'm watching -- nice daily charts >> http://t.co/S6OsZnxnNe
Ben Fidler
29 Jul 14 16:30:22
Seattle Jobs? Big Biotech Gives And Takes Away (Mostly The Latter) http://t.co/ORSvgwhyjx by @alexlash $AMGN $CELG $DNDN $GILD
Companies in News
29 Jul 14 16:21:57
$GILD: Gilead Sciences Inc.'s Upcoming Catalyst(s) http://t.co/V4rzCI4Fho http://t.co/oSDnHKvAzy
29 Jul 14 16:02:36
S&P500 #Stocks Trend $FTR $WIN $MAS $CTL $DRI $WM $WYNN $T $BMY $MPC $CVC $GILD $BIIB $IPG $DD $URBN $HPQ @ http://t.co/ppYlnKK6xM
29 Jul 14 16:02:04
Nasdaq100 #Stocks Trend $WYNN $GILD $BIIB $CTXS $PCLN $AMGN $VOD $CHKP $NTAP $SBAC $BBBY $CTRX $CERN $AAPL @ http://t.co/wz4pxpINCJ
29 Jul 14 16:01:49
Nasdaq100 #Stocks Performance $WFM $WYNN $ESRX $GILD $LLTC $BIIB $COST $SPLS $BBBY $CTRX $FFIV $REGN $CTXS more@ http://t.co/wz4pxpINCJ
29 Jul 14 16:01:34
S&P100 #Stocks Trend $T $BMY $GILD $DD $HPQ $VZ $AMGN $AAPL $TGT $ORCL $ACN $EMC $EBAY $CMCSA $NKE $LOW $COST @ http://t.co/cKkr8ctphu
29 Jul 14 16:01:18
S&P100 #Stocks Performance $T $BMY $GILD $COST $APC $DD $TGT $MRK $HPQ $VZ $LOW $AMGN $EBAY $CAT $CMCSA more@ http://t.co/cKkr8ctphu
Maxim Kreditor, MD
29 Jul 14 15:49:04
@jq1234t @MaverickNY @chasingthealpha @AlpineBV_Miller yep, looks acitve, mb not on label b/c sml #'s; doubt it's a prob 4 $GILD - I hv..
29 Jul 14 15:42:46
@trinijhart @H3NPHLO @ianestepan ARWR's drug is the functional cure vs $GILD's chronic TX. The low market cap, though, points to high risk
Tom Silver
29 Jul 14 15:39:39
$GILD Gilead's Sovaldi prescribed more than all other hepatitis C drugs combined: http://t.co/qyF5yZAPwl via @MercNews
29 Jul 14 15:33:36
@refluxer August approval would be a major earnings boost for the year: $2-3B $GILD
Margaret Dudley
29 Jul 14 15:23:16
RT @hepatitismag: U.S. Senate Opens Investigation on Price of #Hepatitis C Drug Sovaldi $GILD #WorldHepatitisDay http://t.co/a4J2hLuItl
The Panic
29 Jul 14 15:16:41
@JakeFields18 Indeed :-). $GILD
Jon Boorman, CMT
29 Jul 14 14:34:25
361 Capital
29 Jul 14 14:23:18
Stan Wong
29 Jul 14 14:16:28
In Stan Wong Managed Portfolios, Gilead Sciences hits another new all-time high today. $GILD
29 Jul 14 14:01:59
The 5 Best NASDAQ 100 Stocks $BBBY $CSCO $GILD $DTV $ADP http://t.co/AIPq0Et658
Margaret Dudley
29 Jul 14 14:01:11
Gilead Sciences: Make CURE for Hepatitis C affordable for the WORLD http://t.co/jvCYqpne8L via @Change #HepC $GILD #dying4cure
DayTrading Power
29 Jul 14 13:58:34
Daytraded #stocks : $PLUG $CLF $NQ $ARIA $GILD $SPY $CTL $WIN $SYN $BIOF $DDD $DRI $TWTR $PCYC went 15/18 for +$333.50 - 2 TWTR calls O/N
29 Jul 14 13:42:36
$GILD Betcha the #Sovaldi #Ledipasvir combo gets approved in the next month or so well before the 10/10 PDUFA
Companies in News
29 Jul 14 13:22:01
$GILD: Miracle cures spur demand for access to Gilead's $1,000 hepatitis pill http://t.co/ekJvH424ya http://t.co/uUYpOfVRX9
Alexander Daly
29 Jul 14 13:08:20
DCF update: 64 handle on $LO, 17 and change for $BAC, $JPM 84, $MS 26, $HLF 93, $AAPL 98.75, $GILD 115, $IBM 195, $MSFT 42, $KATE 11,
29 Jul 14 13:00:15
S&P500 #Stocks Trend $FTR $WIN $MAS $CTL $DRI $WYNN $WFM $WM $T $XYL $CVC $BMY $BIIB $DD $MRK $GILD $COST $IPG @ http://t.co/ppYlnKK6xM
29 Jul 14 12:59:43
Nasdaq100 #Stocks Trend $WYNN $WFM $BIIB $GILD $COST $AMGN $CTXS $TSLA $PCLN $VOD $NTAP $CHKP $SBAC $BBBY $CERN @ http://t.co/wz4pxpINCJ
29 Jul 14 12:59:27
Nasdaq100 #Stocks Performance $WYNN $WFM $LLTC $ESRX $BIIB $GILD $COST $BRCM $BBBY $SIRI $SPLS $AMGN $FFIV more@ http://t.co/wz4pxpINCJ
29 Jul 14 12:59:12
S&P100 #Stocks Trend $T $BMY $DD $MRK $GILD $COST $VZ $AMGN $HPQ $ORCL $EMC $AAPL $TGT $CMCSA $HD $ACN $NKE @ http://t.co/cKkr8ctphu
29 Jul 14 12:58:56
S&P100 #Stocks Performance $T $BMY $DD $MRK $GILD $COST $TGT $VZ $AMGN $HPQ $CMCSA $CAT $LOW $SBUX $PM more@ http://t.co/cKkr8ctphu
Marija Jukic
29 Jul 14 12:39:58
Gilead Sciences Price Target Increased to $127.00 by Analysts at Maxim Group $GILD http://t.co/3HXMGjwJAM via @RatingsNetwork
Travis Howard
29 Jul 14 12:33:41
$GILD October $97.50 Calls seeing unusual option activity http://t.co/FcRhZRQGov
Daily Contracts
29 Jul 14 12:25:02
Real-Time feed of company contracts, original agreements and executive updates from Gilead Sciences $GILD http://t.co/acEUmAeliX
Nate Brummel
29 Jul 14 12:24:23
Does $GILD break-out after combination for Sovaldi approved in October? #askfast
Stock News Headlines
29 Jul 14 12:22:12
$GILD: Gilead receives positive opinion from CHMP for Zydelig http://t.co/2HNQCz5cZU http://t.co/ThV0UJ8sjD
29 Jul 14 12:19:04
$GILD 100+ in a week?
The Daytrade
29 Jul 14 12:15:44
$GILD monster, going to get $100 magnet pull like $AAPL soon at this pace, total market immunity today, likely more ++ coming tmr
29 Jul 14 12:14:53
RT @aztecs99: @jimcramer 4 horsemen of biotech flexing muscle today - $BIIB $GILD $CELG $REGN -- did u watch this? http://t.co/ixQl4D5mBr
Bill Gunderson
29 Jul 14 12:07:49
I just bought $GILD for my aggressive growth accounts. I already owned it in my large cap conservative accounts.
29 Jul 14 11:45:59
bought my calls back today $GILD for tiny loss. still have short puts at a huge net gain. Will hold those until exp or exercise
Ticker Report
29 Jul 14 11:43:09
Gilead Sciences Price Target Increased to $127.00 by Analysts at Maxim Group $GILD http://t.co/dwjsZrmfyJ

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.